Camden Asset Management »

Ptc Therapeutics shares owned by Camden Asset Management

Quarter-by-quarter ownership of Ptc Therapeutics shares owned by Camden Asset Management from 13F filings

Historical chart of Camden Asset Management investment in Ptc Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics held by Camden Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics by Camden Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $16B 13M 1282.50
2025-06-30 $17B 15M 1151.88